ATC/DDD

ATC/DDD index C10BX

You are here: Home > ATC/DDD > C > C10 > C10B

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- C
CARDIOVASCULAR SYSTEM
- C10
LIPID MODIFYING AGENTS
- C10B
LIPID MODIFYING AGENTS, COMBINATIONS

C10BX

HMG CoA reductase inhibitors, other combinations

ATC/DDD code C10BX for HMG CoA reductase inhibitors, other combinations

The DDD for the fixed combination of rosuvastatin and valsartan is 1 UD (1 tablet), regardless of strength.

C10BX01
simvastatin and acetylsalicylic acid
C10BX02
pravastatin and acetylsalicylic acid
C10BX03
atorvastatin and amlodipine
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us